BACKGROUND: There is increasing evidence suggesting that Chagas disease involves oxidative damage and contributes to heart disease progression. OBJECTIVE: To evaluate the effect of carvedilol on oxidative stress markers in chronic Chagas disease. METHODS: The study population included 42 patients with Chagas cardiomyopathy and oxidative stress biomarkers were measured before and after a period of six months of treatment with carvedilol (37.5 mg/day). Patients were considered according to the Los Andes classification and the activity of superoxide dismutase, catalase, glutathione peroxidase, S-transferase and reductase, myeloperoxidase and adenosine deaminase; levels of reduced glutathione, thiobarbituric acid reactive species, carbonyl protein, vitamin E and nitric oxide were measured in blood. RESULTS: After treatment with carvedilol, all groups showed significant reductions in levels of carbonyl protein and reduced glutathione, whereas the levels of nitric oxide and adenosine activity increased significantly only in group IA. Moreover, most of the antioxidant enzymes showed decrease in activity in groups IA and IB. CONCLUSION: The data suggest that treatment with carvedilol was effective in attenuating oxidative damage, an effect that may be particularly important in patients with chronic Chagas' disease cardiomyopathy.
BACKGROUND: There is increasing evidence suggesting that Chagas disease involves oxidative damage and contributes to heart disease progression. OBJECTIVE: To evaluate the effect of carvedilol on oxidative stress markers in chronic Chagas disease. METHODS: The study population included 42 patients with Chagas cardiomyopathy and oxidative stress biomarkers were measured before and after a period of six months of treatment with carvedilol (37.5 mg/day). Patients were considered according to the Los Andes classification and the activity of superoxide dismutase, catalase, glutathione peroxidase, S-transferase and reductase, myeloperoxidase and adenosine deaminase; levels of reduced glutathione, thiobarbituric acid reactive species, carbonyl protein, vitamin E and nitric oxide were measured in blood. RESULTS: After treatment with carvedilol, all groups showed significant reductions in levels of carbonyl protein and reduced glutathione, whereas the levels of nitric oxide and adenosine activity increased significantly only in group IA. Moreover, most of the antioxidant enzymes showed decrease in activity in groups IA and IB. CONCLUSION: The data suggest that treatment with carvedilol was effective in attenuating oxidative damage, an effect that may be particularly important in patients with chronic Chagas' disease cardiomyopathy.
Authors: Augusto Cardinalli-Neto; Adalberto M Lorga-Filho; Elissandro F Silva; Renata P Lima; Eduardo Palmegiani; Reinaldo B Bestetti Journal: Int J Cardiol Heart Vasc Date: 2015-10-19
Authors: Aline Luciano Horta; Ana Luisa Junqueira Leite; G Paula Costa; Vivian Paulino Figueiredo; André Talvani Journal: Biomed Res Int Date: 2017-03-09 Impact factor: 3.411
Authors: Juana P Sánchez-Villamil; Paula K Bautista-Niño; Norma C Serrano; Melvin Y Rincon; Nisha J Garg Journal: Oxid Med Cell Longev Date: 2020-03-26 Impact factor: 6.543
Authors: Aline Luciano Horta; Vivian Paulino Figueiredo; Ana Luisa Junqueira Leite; Guilherme de Paula Costa; Ana Paula de Jesus Menezes; Camila de Oliveira Ramos; Tamiles Caroline Fernandes Pedrosa; Frank Silva Bezerra; Paula Melo de Abreu Vieira; André Talvani Journal: Mem Inst Oswaldo Cruz Date: 2018-10-18 Impact factor: 2.743